Daiichi Sankyo, Merck collaborate to develop and commercialize three Daiichi Sankyo DXd ADCs
Merck to pay Daiichi Sankyo a $4 billion upfront payment in addition to $1.5 billion in continuation payments over the next 24 months
Merck to pay Daiichi Sankyo a $4 billion upfront payment in addition to $1.5 billion in continuation payments over the next 24 months
SigTuple’s AI100 with Shonit is the premier solution for AI assisted digital pathology
The hospital hosted a two-day event with top internal and external faculty and medical experts
This exposé embarks on an illuminative journey, unfurling the crucial stratagems imperative for upholding public health, achieved through the unyielding fortress of pharmaceutical quality safeguards
Mankind Pharma's initiative aims to ensure universal access to medicines of international calibre
The deal represents a total transaction value of up to $36 million with an initial upfront consideration of $14 million
ELREXFIO’s label contains a boxed warning for cytokine release syndrome and neurologic toxicity
Approval to dramatically change CAR-T therapies landscape
Subscribe To Our Newsletter & Stay Updated